The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: The CTX-M-15 type consolidation

Future Microbiology

Volumn 10, Issue 6, 2015, Pages 1063-1075

  Calbo, Esther ^a,b   Garau, Javier ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

extended spectrum lactamase; hospital outbreak; Klebsiella pneumoniae; lactamase CTX M 15

Indexed keywords

BACTERIAL ENZYME; CARBAPENEM DERIVATIVE; CTX M 15 ENZYME; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE CTX-M-15;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM DETECTION; EPIDEMIC; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; CROSS INFECTION; DRUG UTILIZATION; ENZYMOLOGY; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; PREVALENCE; PROCEDURES; SECRETION (PROCESS); STANDARDS;

ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG UTILIZATION; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; PREVALENCE;

EID: 84930985419     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.15.22     Document Type: Review

References (85)

1. Nugent M, Hedges RW. The nature of the genetic determinant for the SHV-1 beta-lactamase. Mol. Gen. Genet. 175(3), 239-243 (1979).
2. Antimicrobial resistance: global report on surveillance 2014. www.who.int/drugresistance/documents
3. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev. Anti Infect. Ther. 6(5), 751-763 (2008).
4. A worldwide database for nosocomial outbreaks. www.outbreak-database.com
5. Cotton MF, Wasserman E, Pieper CH et al. Invasive disease due to extended spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: the possible role of cockroaches. J. Hosp. Infect. 44(1), 13-17 (2000).
6. Parasakthi N, Vadivelu J, Ariffin H et al. Epidemiology and molecular characterization of nosocomially transmitted multidrugresistant Klebsiella pneumoniae. Int. J. Infect. Dis. 4(3), 123-128 (2000).
7. Rebuck JA, Olsen KM, Fey PD et al. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population. Clin. Infect. Dis. 31(6), 1368-1372 (2000).
8. Fiett J, Paucha A, Miaczyska B et al. A novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing Klebsiella. Antimicrob. Agents Chemother. 44(6), 1499-1505 (2000).
9. Macrae MB, Shannon KP, Rayner DM et al. A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. J. Hosp. Infect. 49(3), 183-192 (2001).
10. Silva J, Gatica R, Aguilar C et al. Outbreak of infection with extended-spectrum betalactamase-producing Klebsiella pneumoniae in a Mexican hospital. J. Clin. Microbiol. 39(9), 3193-3196 (2001).
11. Gonzalez-Vertiz A, Alcantar-Curiel D, Cuauhtli M et al. Multiresistant extendedspectrum beta-lactamase-producing Klebsiella pneumoniae causing an outbreak of nosocomial bloodstream infection. Infect. Control Hosp. Epidemiol. 22(11), 723-725 (2001).
12. Komatsu M, Ikeda N, Aihara M et al. Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae. J. Infect. Chemother. 7(2), 94-101 (2001).
13. Quale JM, Landman D, Bradford PA et al. Molecular epidemiology of a citywide outbreak of extended-spectrum betalactamase-producing Klebsiella pneumoniae infection. Clin. Infect. Dis. 35(7), 834-841 (2002).
14. Pessoa-Silva CL, Meurer Moreira B, Camara Almeida V et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J. Hosp. Infect. 53(3), 198-206 (2003).
15. Ayan M, Kuzucu C, Durmaz R et al. Analysis of three outbreaks due to Klebsiella species in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol. 24(7), 495-500 (2003).
16. Gruteke P, Goessens W, Van Gils J et al. Patterns of resistance associated with integrons, the extended-spectrum betalactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J. Clin. Microbiol. 41(3), 1161-1166 (2003).
17. Brenwald NP, Jevons G, Andrews JM et al. An outbreak of a CTX-M-type betalactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 51(1), 195-196 (2003).
18. Ben-Hamouda T, Foulon T, Ben-Cheikh-Masmoudi A et al. Molecular epidemiology of an outbreak of multiresistant Klebsiella pneumoniae in a Tunisian neonatal ward. J. Med. Microbiol. 52(Pt5), 427-433 (2003).
19. Duarte A, Boavida F, Grosso F et al. Outbreak of GES-1 beta-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob. Agents Chemother. 47(4), 1481-1482 (2003).
20. Cartelle M, del Mar Tomas M, Pertega S et al. Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins. J. Clin. Microbiol. 42(9), 4242-4249 (2004).
21. Gupta A, Della-Latta P, Todd B et al. Outbreak of extended-spectrum betalactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails. Infect. Control Hosp. Epidemiol. 25(3), 210-215 (2004).
22. Miranda G, Castro N, Leanos B et al. Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extendedspectrum beta-lactamase in a Mexican pediatric hospital. J. Clin. Microbiol. 42(1), 30-35 (2004).
23. Bouallegue-Godet O, Grimont F, Ben Salem Y et al. Investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases in a neonatal ward, Sousse, Tunisia. Pathol. Biol. 53(2), 75-80 (2005).
24. Boszczowski I, Nicoletti C, Puccini DM et al. Outbreak of extended spectrum betalactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker. Pediatr. Infect. Dis. J. 24(7), 648-650 (2005).
25. Krawczyk B, Samet A, Czarniak E et al. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal unit: control of an outbreak using a new ADSRRS technique. Pol. J. Microbiol. 54(2), 105-110 (2005).
26. Moodley P, Coovadia YM, Sturm AW. Intravenous glucose preparation as the source of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infections in the neonatal unit of a regional hospital in KwaZulu-Natal. S. Afr. Med. J. 95(11), 861-864 (2005).
27. Van 't Veen A, van der Zee A, Nelson J et al. Outbreak of infection with a multiresistant Klebsiella pneumoniae strain associated with contaminated roll boards in operating rooms. J. Clin. Microbiol. 43, 4961-4967 (2005).
28. Mamlouk K, Boutiba-Ben Boubaker I, Gautier V et al. Emergence and outbreaks of CTX-M beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian hospital. J. Clin. Microbiol. 44(10), 4049-4056 (2006).
29. Cassettari VC, Silveira IR, Balsamo AC et al. Outbreak of extended-spectrum betalactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit linked to onychomycosis in a healthcare worker. J. Pediatr. (Rio J.). 82(4), 313-316 (2006).
30. Cassettari VC, da Silveira IR, Dropa M et al. Risk factors for colonisation of newborn infants during an outbreak of extendedspectrum beta-lactamase-producing Klebsiella pneumoniae in an intermediate-risk neonatal unit. J. Hosp. Infect. 71(4), 340-347 (2009).
31. Mena A, Plasencia V, Garcia L et al. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J. Clin. Microbiol. 44(8), 2831-2837 (2006).
32. Mazzariol A, Roelofsen E, Koncan R et al. Detection of a new SHV-type extendedspectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands. Antimicrob. Agents Chemother. 51(3), 1082-1084 (2007).
33. Laurent C, Rodriguez-Villalobos H, Rost F et al. Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect. Control Hosp. Epidemiol. 29(6), 517-524 (2008).
34. De Oliveira Garcia D, Doi Y, Szabo D et al. Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil. Antimicrob. Agents Chemother. 52(5), 1790-1793 (2008).
35. Ko KS, Yeom JS, Lee MY et al. Clonal dissemination of extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae isolates in a Korean hospital. J. Korean Med. Sci. 23(1), 53-60 (2008).
36. Velasco C, Rodriguez-Bano J, Garcia L et al. Eradication of an extensive outbreak in a neonatal unit caused by two sequential Klebsiella pneumoniae clones harbouring related plasmids encoding an extendedspectrum beta-lactamase. J. Hosp. Infect. 73(2), 157-163 (2009).
37. Lytsy B, Sandegren L, Tano E et al. The first major extended-spectrum beta-lactamase outbreak in Scandinavia was caused by clonal spread of a multiresistant Klebsiella pneumoniae producing CTX-M-15. APMIS 116(4), 302-308 (2008).
38. Carrer A, Lassel L, Fortineau N et al. Outbreak of CTX-M-15-producing Klebsiella pneumoniae in the intensive care unit of a French hospital. Microb. Drug Resist. 15(1), 47-54 (2009).
39. Randrianirina F, Vedy S, Rakotovao D et al. Role of contaminated aspiration tubes in nosocomial outbreak of Klebsiella pneumoniae producing SHV-2 and CTX-M-15 extendedspectrum beta-lactamases. J. Hosp. Infect. 72(1), 23-29 (2009).
40. Vranic-Ladavac M, Bosnjak Z, Beader N et al. Clonal spread of CTX-M-15-producing Klebsiella pneumoniae in a Croatian hospital. J. Med. Microbiol. 59(Pt 9), 1069-1078 (2010).
41. Aumeran C, Poincloux L, Souweine B et al. Multidrug-resistant Klebsiella pneumoniae outbreak after endoscopic retrograde cholangiopancreatography. Endoscopy 42(11), 895-899 (2010).
42. Dumpis U, Iversen A, Balode A et al. Outbreak of CTX-M-15-producing Klebsiella pneumoniae of sequence type 199 in a Latvian teaching hospital. APMIS 118(9), 713-716 (2010).
43. Dedeic-Ljubovic A, Hukic M, Pfeifer Y et al. Emergence of CTX-M-15 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Bosnia and Herzegovina. Clin. Microbiol. Infect. 16(2), 152-156 (2010).
44. Calbo E, Freixas N, Xercavins M et al. Foodborne nosocomial outbreak of SHV1 and CTX-M-15-producing Klebsiella pneumoniae: epidemiology and control. Clin. Infect. Dis. 52(6), 743-749 (2011).
45. Webster DP, Young BC, Morton R et al. Impact of a clonal outbreak of extendedspectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK. J. Antimicrob. Chemother. 66(9), 2126-2135.
46. Damjanova I, Toth A, Kenesei E et al. Dissemination of ST274 Klebsiella pneumoniae epidemic clone in newborn and adult hospital settings harbouring SHV-2A or CTX-M-15 type extended spectrum β-lactamases-producing known plasmids. Eur. J. Microbiol. Immunol. (Bp) 1(3), 223-227 (2011).
47. Guyot K, Biran V, Doit C et al. Raman spectroscopic analysis of the clonal and horizontal spread of CTX-M-15-producing Klebsiella pneumoniae in a neonatal intensive care unit. Eur. J. Clin. Microbiol. Infect. Dis. 31(10), 2827-2834 (2012).
48. Lin R, Wu B, Xu XF et al. Extendedspectrum beta-lactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit. World J. Pediatr. 8(3), 268-271 (2012).
49. Rettedal S, Hoyland Lohr I, Natas O et al. Risk factors for acquisition of CTX-M-15 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae during an outbreak in a neonatal intensive care unit in Norway. Scand. J. Infect. Dis. 45(1), 54-58 (2013).
50. Poulou A, Voulgari E, Vrioni G et al. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. J. Clin. Microbiol. 51(10), 3176-3182 (2013).
51. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11(6), 315-317 (1983).
52. Canton R, Novais A, Valverde A et al. Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14(Suppl. 1), 144-153 (2008).
53. The Lactamase Engineering Database www.laced.uni-stuttgart.de/
54. Lahey Clinic s-lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. www.lahey.org/Studies/
55. Bauernfeind A, Grimm H, Schweighart S. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18(5), 294-298 (1990).
56. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8(3), 159-166 (2008).
57. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66(1), 1-14 (2011).
58. s-lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. www.lahey.org/studies/other.asp#table-1
59. Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9(5), 466-475 (2006).
60. Calbo E, Romani V, Xercavins M et al. Risk factors for community-onset urinary tract infections due to Escherichia coli harboring extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 57(4), 780-783 (2006).
61. Denisuik AJ, Lagace-Wiens PR, Pitout JD et al. Molecular epidemiology of extendedspectrum β-lactamase-, AmpC β-lactamaseand carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11. J. Antimicrob. Chemother. 68(Suppl. 1), i57-i65 (2013).
62. Oteo J, Cuevas O, Lopez-Rodriguez I et al. Emergence of CTX-M-15-producing Klebsiella pneumoniae of multilocus sequence types 1, 11, 14, 17, 20, 35 and 36 as pathogens and colonizers in newborns and adults. J. Antimicrob. Chemother. 64(3), 524-528 (2009).
63. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35(5), 736-755 (2011).
64. Damjanova I, Toth A, Paszti J et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005 - the new 'MRSAs'? J. Antimicrob. Chemother. 62(5), 978-985 (2008).
65. Webster DP, Young BC, Morton R. Impact of a clonal outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK. J. Antimicrob. Chemother. 66(9), 2126-2135 (2011).
66. Ko KS, Lee JY, Baek JY et al. Predominance of an ST11 extended-spectrum betalactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J. Med. Microbiol. 59(Pt7), 822-828 (2010).
67. Tato M, Coque TM, Ruiz-Garbajosa P et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-betalactamase in Spain: toward endemicity? Clin. Infect. Dis. 45(9) 1171-1178 (2007).
68. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. www.eucast.org/fileadmin/src/media/PDFs
69. Poulou A, Grivakou E, Vrioni G et al. Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases. J. Clin. Microbiol. 52(5), 1483-1489 (2014).
70. Tacconelli E, Cataldo MA, Dancer SJ et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin. Microbiol. Infect. 20(Suppl. 1), 1-55 (2014).
71. Kader AA, Kumar A, Kamath KA. Fecal carriage of extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect. Control Hosp. Epidemiol. 28(9), 1114-1116 (2007).
72. Andriatahina T, Randrianirina F, Hariniana ER et al. High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar. BMC Infect. Dis. 10,204 (2010).
73. Isendahl J, Turlej-Rogacka A, Manjuba C, Rodrigues A, Giske CG, Naucler P. Fecal carriage of ESBL-producing E. Coli and K. pneumoniae in children in Guinea-Bissau: a hospital-based cross-sectional study. PLoS ONE 7(12), e51981 (2012).
74. Valverde A, Coque TM, Garcia-San Miguel L, Baquero F, Canton R. Complex molecular epidemiology of extended-spectrum beta-lactamases in Klebsiella pneumoniae: a long-term perspective from a single institution in Madrid. J. Antimicrob. Chemother. 61(1), 64-72 (2008).
75. Dolejska M, Frolkova P, Florek M et al. CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. J. Antimicrob. Chemother. 66(12) 2784-2790 (2011).
76. Lavilla S, Gonzalez-Lopez JJ, Miro E et al. Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson. J. Antimicrob. Chemother. 61(6), 1244-1251 (2008).
77. Donati V, Feltrin F, Hendriksen RS et al. Extended-spectrum-beta-lactamases, AmpC beta-lactamases and plasmid mediated quinolone resistance in Klebsiella spp. from companion animals in Italy. PLoS ONE 9(3), e90564 (2014).
78. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9(4), 228-236 (2009).
79. Martinez P, Sanchez L, Mattar S. Carbapenemase KPC-2 in ESBL-producing Enterobacteriaceae from two clinics from Villavicencio, Colombia. Braz. J. Infect. Dis. 18(1), 100-101 (2014).
80. Chiu SK, Wu TL, Chuang YC et al. National surveillance study on carbapenem nonsusceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS ONE 8(7), e69428 (2013).
81. Miriagou V, Tzelepi E, Daikos GL et al. Panresistance in VIM-1-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 55(5), 810-811 (2005).
82. Cagnacci S, Gualco L, Roveta S et al. Bloodstream infections caused by multidrugresistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallobeta-lactamase: first Italian outbreak. J. Antimicrob. Chemother. 61(2), 296-300 (2008).
83. Miro E, Segura C, Navarro F et al. Spread of plasmids containing the bla(VIM-1) and bla(CTX-M) genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. J. Antimicrob. Chemother. 65(4), 661-665 (2010).
84. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17(10), 1791-1798 (2011).
85. Kalpoe JS, Al Naiemi N, Poirel L, Nordmann P. Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands. J. Med. Microbiol. 60(Pt5), 677-678 (2011).